n Obstetrics and Gynaecology Forum - FDG PET imaging in Gynaecology : guest editorial

Volume 20, Issue 2
  • ISSN : 1027-9148



The time has come for the South African medical community to graduate from viewing PET as "Pretty Expensive Technology" or "Promising Emerging Technology". For Positron Emission Tomography (PET) with F-18 fluoro-2-deoxy-D-glucose (FDG) is now the standard of care in initial staging, monitoring the response to therapy, and management of various cancers. This is due to fact that PET is a molecular imaging procedure that allows us to obtain three-dimensional images of what is happening in a patient's body at the molecular and cellular levels. The commonly used radiopharmaceutical, FDG, which is an analogue of glucose, provides qualitative and quantitative metabolic information that is valuable for diagnosis and management of tumors or cancer cells. Of importance, PET is now combined with morphologic information obtained with CT.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error